Ascendis Pharma A/S

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ASND and other ETFs, options, and stocks.

About ASND

Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs. 

CEO
Jan Møller Mikkelsen
CEOJan Møller Mikkelsen
Employees
—
Employees—
Headquarters
Hellerup, Capital Region
HeadquartersHellerup, Capital Region
Founded
2006
Founded2006
Employees
—
Employees—

ASND Key Statistics

Market cap
17.57B
Market cap17.57B
Price-Earnings ratio
18.70
Price-Earnings ratio18.70
Dividend yield
—
Dividend yield—
Average volume
668.29K
Average volume668.29K
High today
$269.85
High today$269.85
Low today
$258.50
Low today$258.50
Open price
$264.73
Open price$264.73
Volume
819.62K
Volume819.62K
52 Week high
$282.15
52 Week high$282.15
52 Week low
$188.07
52 Week low$188.07

Stock Snapshot

As of today, Ascendis Pharma A/S(ASND) shares are valued at $267.60. The company's market cap stands at 17.57B, with a P/E ratio of 18.70.

On 2026-11-12, Ascendis Pharma A/S(ASND) stock traded between a low of $258.50 and a high of $269.85. Shares are currently priced at $267.60, which is +3.5% above the low and -0.8% below the high.

Ascendis Pharma A/S(ASND) shares are trading with a volume of 819.62K, against a daily average of 668.29K.

During the past year, Ascendis Pharma A/S(ASND) stock moved between $188.07 at its lowest and $282.15 at its peak.

During the past year, Ascendis Pharma A/S(ASND) stock moved between $188.07 at its lowest and $282.15 at its peak.

ASND News

Benzinga 6h
Ascendis Pharma Q3 2026 Earnings Call Transcript - Benzinga

...

Ascendis Pharma Q3 2026 Earnings Call Transcript - Benzinga
TipRanks 6h
Ascendis Pharma Files Unaudited September 2026 Financial Statements

Ascendis Pharma ( (ASND) ) just unveiled an announcement. On November 12, 2026, Ascendis Pharma filed unaudited interim financial statements and management’s d...

Simply Wall St 6d
Ascendis Pharma Stock May Trade At A Discount As EU Exclusivity Nears

has quietly put together a solid run over the past month, which puts a fresh spotlight on whether the current share price lines up with what its earnings can su...

Ascendis Pharma Stock May Trade At A Discount As EU Exclusivity Nears

Analyst ratings

95%

of 22 ratings
Buy
95.5%
Hold
4.5%
Sell
0%

People also own

Based on the portfolios of people who own ASND. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.